[Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients]. (Q50860211)

24 March 2018

title

[Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients]. (English)

1 reference

24 March 2018

0 references

1 reference

M A Cordoliani

1

1 reference

24 March 2018

U Michon-Pasturel

2

1 reference

24 March 2018

K Rerat

3

1 reference

24 March 2018

J Arvieux

4

1 reference

24 March 2018

E Masy

5

1 reference

24 March 2018

E Hachulla

6

1 reference

24 March 2018

P Vermersch

7

1 reference

24 March 2018

language of work or name

French

0 references

publication date

1 September 1998

1 reference

24 March 2018

Revue de Médecine Interne

published in

1 reference

24 March 2018

volume

19

1 reference

24 March 2018

issue

9

1 reference

24 March 2018

page(s)

635-639

1 reference

24 March 2018

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Neurological disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Antiphospholipid antibodies and cerebral ischemia in young people

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Neurological involvement in antiphospholipid syndrome: clinical and instrumental evaluation in 21 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Neurologic manifestations associated with antiphospholipid antibodies. Or what remains of neurolupus?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Cerebrospinal fluid and serum antiphospholipid antibodies in multiple sclerosis, Guillain-Barré syndrome and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Anticardiolipin antibodies in Japanese patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

A collagen disorder of the nervous system presenting as multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Criteria for the clinical diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Anticardiolipin antibodies in MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

Frequency and significance of antinuclear antibodies in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2899%2980042-3

7 January 2021

10.1016/S0248-8663(99)80042-3

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018